News 15 May 2026 GlueGene Therapeutics Unveils AAV Vector Primate Targeting Results at ASGCT 2026 GGT-100 Vector achieves precision targeting of pulmonary artery smooth muscle cells in non-human primates GlueGene Therapeutics (CEO Moon-soo Lee), a… GluGene